ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 67 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $28,000 | – | 6,101 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 5,292,156 | $7,144,000 | 0.82% |
| Northeast Financial Consultants Inc | 732,265 | $988,000 | 0.30% |
| Family Management Corp | 10,424 | $14,000 | 0.01% |
| LMR Partners LLP | 81,550 | $110,000 | 0.01% |
| ELEMENT CAPITAL MANAGEMENT LLC | 148,528 | $201,000 | 0.01% |
| Poehling Capital Management, INC. | 3,302 | $4,000 | 0.00% |
| Paloma Partners Management Co | 143,800 | $194,000 | 0.00% |
| Founders Capital Management | 3,000 | $4,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 186,254 | $251,000 | 0.00% |
| FNY Investment Advisers, LLC | 4,230 | $5,000 | 0.00% |